| 注册
首页|期刊导航|辽宁中医杂志|黄连解毒汤治疗帕金森病认知功能障碍患者临床研究

黄连解毒汤治疗帕金森病认知功能障碍患者临床研究

张哲 靳晓飞 武萌萌 曹利红 苏志伟

辽宁中医杂志2026,Vol.53Issue(4):98-101,4.
辽宁中医杂志2026,Vol.53Issue(4):98-101,4.DOI:10.13192/j.issn.1000-1719.2026.04.024

黄连解毒汤治疗帕金森病认知功能障碍患者临床研究

Clinical Study on Huanglian Jiedu Decoction(黄连解毒汤)in Treatment of Parkinson's Disease Patients with Cognitive Impairment

张哲 1靳晓飞 1武萌萌 1曹利红 1苏志伟1

作者信息

  • 1. 河北省中医院,河北 石家庄 050000
  • 折叠

摘要

Abstract

Objective To explore the effect of Huanglian Jiedu Decoction(黄连解毒汤)on neurotrophin,brain neurotransmit-ters and clinical efficacy in the treatment of Parkinson's disease(PD)patients with cognitive impairment.Method:A total of 120 PD patients with cognitive impairment admitted the hospital from February 2021 to February 2023 were divided into treatment group(60 cases)and control group(60 cases).The control group was treated with western medicine and the treatment group was combined with Huanglian Jiedu Decoction on thee basis of the control group.The treatment period of the two groups lasted for 12 weeks.The clinical efficacy of the two groups after 12 weeks of treatment was compared,and the effects of cognitive function,de-gree of illness and activities of daily living,neurotrophin,brain neurotransmitters and quality of life before and after 12 weeks of treatment were compared.Result The effective rate of the treatment group was higher than that of the control group(P<0.05).After 12 weeks of treatment,the mini-mental state examination(MMSE)scores and Montreal cognitive assessment(MoCA)scores of the two groups were higher than those before treatment(P<0.05).The scores of the treatment group were higher than those of the control group(P<0.05).After 12 weeks of treatment,the unified Parkinson's disease rating scale(UPDRS)scores of the two groups were lower than those before treatment,and the score of the treatment group was lower than that of the control group(P<0.05).The activities of daily living(ADL)scores were higher than those before treatment(P<0.05)and the ADL score in the treatment group was higher than that of the control group(P<0.05).After 12 weeks of treatment,the levels of brain-derived neurotrophic factor(BDNF)and glial cell line derived neurotrophic factor(GDNF)in both groups were higher than those before treatment(P<0.05).The levels in the treatment group were higher than those in the control group(P<0.05).After 12 weeks of treatment,the levels of homocysteine(Hey)and acetylcholinesterase(AChE)in both groups were lower than those before treat-ment,and the levels of the treatment group were lower than those of the control group(P<0.05).The levels of acetylcholine(Ach)in both groups were higher than those before treatment,and the level of the treatment group was higher than that of the con-trol group(P<0.05).After 12 weeks of treatment,the scores of the Parkinson's disease quality of life questionnaire(PDQ-39)in both groups were lower than those before treatment(P<0.05).The score of the treatment group was lower than that of the con-trol group(P<0.05).Conclusion Huanglian Jiedu Decoction can increase the levels of BDNF and GDNF,down-regulate the levels of Hey and AChE,and up-regulate the level of Ach in the PD patients with cognitive impairment.It has significant effects,and can improve cognitive function and quality of life.

关键词

黄连解毒汤/帕金森病/认知功能障碍/神经营养因子/脑神经递质/临床疗效

Key words

Huanglian Jiedu Decoction(黄连解毒汤)/Parkinson's disease/cognitive impairment/neurotrophin/brain neuro-transmitters/clinical efficacy

分类

医药卫生

引用本文复制引用

张哲,靳晓飞,武萌萌,曹利红,苏志伟..黄连解毒汤治疗帕金森病认知功能障碍患者临床研究[J].辽宁中医杂志,2026,53(4):98-101,4.

基金项目

国家中医药管理局全国名中医传承工作室建设项目(2018年) (2018年)

河北省中医药管理局科研计划项目(2020088) (2020088)

河北省自然科学基金项目(H2022423382) (H2022423382)

河北省中医药管理局科研计划项目(2021101) (2021101)

5.河北省研究生创新资助项目(CXZZBS2023138) (CXZZBS2023138)

辽宁中医杂志

1000-1719

访问量0
|
下载量0
段落导航相关论文